14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Aug 25, 2016 $23.60 $23.60 $23.60 $23.60 65 175
Aug 24, 2016 $24.32 $24.32 $24.32 $24.32 75 913
Aug 23, 2016 $25.76 $25.76 $25.76 $25.76 76 350
Aug 22, 2016 $25.52 $25.52 $25.52 $25.52 29 125
Aug 19, 2016 $25.04 $25.04 $25.04 $25.04 42 450
Aug 18, 2016 $27.04 $27.04 $27.04 $27.04 40 325
Aug 17, 2016 $27.60 $27.60 $27.60 $27.60 67 138
Aug 16, 2016 $27.36 $27.36 $27.36 $27.36 218 675
Aug 15, 2016 $25.36 $25.36 $25.36 $25.36 59 225
Aug 12, 2016 $24.56 $24.56 $24.56 $24.56 37 513
Aug 11, 2016 $24.08 $24.08 $24.08 $24.08 37 388
Aug 10, 2016 $24.16 $24.16 $24.16 $24.16 59 838
Aug 09, 2016 $24.64 $24.64 $24.64 $24.64 48 088
Aug 08, 2016 $24.72 $24.72 $24.72 $24.72 37 113
Aug 05, 2016 $25.36 $25.36 $25.36 $25.36 47 675
Aug 04, 2016 $26.00 $26.00 $26.00 $26.00 67 800
Aug 03, 2016 $25.12 $25.12 $25.12 $25.12 47 275
Aug 02, 2016 $24.24 $24.24 $24.24 $24.24 47 163
Aug 01, 2016 $24.40 $24.40 $24.40 $24.40 52 825
Jul 29, 2016 $24.64 $24.64 $24.64 $24.64 39 238
Jul 28, 2016 $24.48 $24.48 $24.48 $24.48 30 050
Jul 27, 2016 $24.72 $24.72 $24.72 $24.72 42 213
Jul 26, 2016 $24.72 $24.72 $24.72 $24.72 44 738
Jul 25, 2016 $24.56 $24.56 $24.56 $24.56 25 938
Jul 22, 2016 $24.72 $24.72 $24.72 $24.72 42 550
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT